Tremor revisited: Treatment of PD tremor

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Jiménez, Mayté Castro ^a   Vingerhoets, Francois J G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Deep brain stimulation; Parkinsonian tremor; Pharmacological; Stereotactic surgery

Indexed keywords

AMANTADINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUDIPINE; CABERGOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PERGOLIDE; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; RASAGILINE; ROPINIROLE; SELEGILINE; TOPIRAMATE; ZONISAMIDE;

ADD ON THERAPY; ADJUVANT THERAPY; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; ESSENTIAL TREMOR; GAMMA KNIFE RADIOSURGERY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LOW DRUG DOSE; MONOTHERAPY; MUSCLE RIGIDITY; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEREOTAXIC SURGERY; THALAMOTOMY; TREMOR; UNSPECIFIED SIDE EFFECT;

EID: 84858682541     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70030-x     Document Type: Article

References (22)

1. Raethjen J, Pohle S, Govindan RB, Morsnowski A, Wenzelburger R, Deuschl G. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response Exp Neurol 2005;194(1):151-60.
2. Leu-Semenescu S, Roze E, Vidailhet M, Legrand AP, Trocello JM, Cochen V, Sangla S, Apartis E Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord 2007;22(14):2063-9.
3. Milanov I. A cross-over clinical and electromyographic assessment of treatment of parkinsonian tremor. Parkinsonism Relat Disord 2001;8(1):67-73.
4. Deuschl G, Papengut F, Hellriegel H. The phenomenology of Parkinsonian tremor. Parkinsonism Relat Disord 2012;18(Suppl 1):S87-9.
5. Baumann CR. Epidemiology, diagnosis and differential diagnosis in Parkinson's disease tremor. Parkinsonism Relat Disord 2012;18(Suppl 1):S90-2.
6. Katzenschlager R, Sampaio C, Costa J, Lees A. Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev 2003;(2): CD003735.
7. Henderson JM, Yiannikas C, Morris JG, Einstein R, Jackson D, Byth K. Postural tremor of Parkinson's disease. Clinical Neuropharm 1994;17(3):277-85.
8. Parkinson Study Group. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Arch Neurol 2005;62(2):241-8.
9. Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, et al. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev 2008; (2):CD006564.
10. Fishman PS. Paradoxical aspects of parkinsonian tremor. Mov Disord 2008;23(2): 168-73.
11. Crosby N, Deane KH, Clarke CE. Amantadine in Parkinson's disease. Cochrane Database Syst Rev 2003;(1): CD003468.
12. Thomas AA, Friedman JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol 2010;33(1):14-6.
13. Reichmann H. Budipine in Parkinson's tremor. J Neurol Sci 2006;248(1-2): 53-5.
14. Crosby NJ, Deane KH, Clarke CE. Beta-blocker therapy for tremor in Parkinson's disease. Cochrane Database Syst Rev 2003;(1):CD003361.
15. Murata M, Hasegawa K, Kanazawa I. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology 2007;68: 45-50.
16. Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, et al.; European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol 2006;13(11):1186-202.
17. Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011;68(2):165.
18. Schuurman PR, Bosch DA, Merkus MP, Speelman JD. Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression Mov Disord 2008;23(8):1146-53.
19. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Longterm results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25(5):578-86.
20. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al; CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362(22):2077-91.
21. Lim SY, Hodaie M, Fallis M, Poon YY, Mazzella F, Moro E. Gamma knife thalamotomy for disabling tremor: a blinded evaluation. Arch Neurol 2010;67(5):584-8.
22. Blomstedt P, Sandvik U, Fytagoridis A, Tisch S. The posterior subthalamic area in the treatment of movement disorders: past, present, and.future. Neurosurgery 2009;64(6):1029-38; discussion 1038-42.